Sinsin Pharmaceutical Co., Ltd (KOSDAQ: 002800)

Market Cap	94.66B
Revenue (ttm)	105.25B
Net Income (ttm)	4.05B
Shares Out	15.17M
EPS (ttm)	266.49
PE Ratio	23.42
Forward PE	n/a
Dividend	60.00 (0.96%)
Ex-Dividend Date	n/a

Volume	106,406
Open	6,280.00
Previous Close	6,270.00
Day's Range	6,180.00 - 6,530.00
52-Week Range	4,915.00 - 8,540.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Sinsin Pharmaceutical

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The co...

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 338
• Stock Exchange: KOSDAQ
• Ticker Symbol: 002800

Financial Performance

In 2023, Sinsin Pharmaceutical's revenue was 102.59 billion, an increase of 11.60% compared to the previous year's 91.93 billion. Earnings were 4.68 billion, an increase of 6.01%.